Tsai C, Li C, Li J, Jang B, Chen S
J Fluoresc. 2016; 26(4):1239-48.
PMID: 27165037
DOI: 10.1007/s10895-016-1811-6.
Hawkins R, Sangster K, Krajewski A
Br J Cancer. 1987; 55(6):611-6.
PMID: 3620302
PMC: 2002028.
DOI: 10.1038/bjc.1987.124.
Roberts M, Hawkins R, Alexander F, Anderson T, Steele R
Breast Cancer Res Treat. 1987; 10(3):267-72.
PMID: 3447645
DOI: 10.1007/BF01805763.
Scheres H, de Goeij A, Rousch M, Hondius G, Willebrand D, GIJZEN A
J Clin Pathol. 1988; 41(6):623-32.
PMID: 3384997
PMC: 1141542.
DOI: 10.1136/jcp.41.6.623.
Rutqvist L, Cedermark B, Glas U, Johansson H, Nordenskjold B, Skoog L
Breast Cancer Res Treat. 1987; 10(3):255-66.
PMID: 3328986
DOI: 10.1007/BF01805762.
The relevance of control histology in oestrogen receptor estimation.
Steele R, Hawkins R, Anderson T, Forrest A
Br J Cancer. 1987; 56(5):617-8.
PMID: 3322353
PMC: 2001888.
DOI: 10.1038/bjc.1987.252.
Immunohistology of oestrogen receptor and D5 antigen in breast cancer: correlation with oestrogen receptor content of adjacent cryostat sections assayed by radioligand binding and enzyme immunoassay.
Giri D, Dangerfield V, Lonsdale R, Rogers K, Underwood J
J Clin Pathol. 1987; 40(7):734-40.
PMID: 3305584
PMC: 1141089.
DOI: 10.1136/jcp.40.7.734.
The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy.
Hawkins R, Sangster K, Tesdale A, Levack P, Anderson E, Chetty U
Br J Cancer. 1988; 58(1):77-80.
PMID: 3166894
PMC: 2246505.
DOI: 10.1038/bjc.1988.166.
Oestrogen receptor activity in intraduct and invasive breast carcinomas.
Hawkins R, Tesdale A, FERGUSON W, Going J
Breast Cancer Res Treat. 1987; 9(2):129-33.
PMID: 3040158
DOI: 10.1007/BF01807365.
Assessment of oestrogen receptor content of breast carcinoma by immunohistochemical techniques on fixed and frozen tissue and by biochemical ligand binding assay.
Paterson D, Reid C, Anderson T, Hawkins R
J Clin Pathol. 1990; 43(1):46-51.
PMID: 2312751
PMC: 502223.
DOI: 10.1136/jcp.43.1.46.
The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast.
Winstanley J, Cooke T, George W, Murray G, Holt S, Croton R
Br J Cancer. 1991; 64(1):99-101.
PMID: 1854633
PMC: 1977324.
DOI: 10.1038/bjc.1991.249.
Classical oestrogen receptor is not detectable in pancreatic adenocarcinoma.
TAYLOR O, Teasdale J, Cowen P, McMahon M, Benson E
Br J Cancer. 1992; 66(3):503-6.
PMID: 1520587
PMC: 1977934.
DOI: 10.1038/bjc.1992.303.
Change in the oestrogen receptor status of breast cancer with age--comparison of two types of assay.
Gaskell D, Sangster K, Tesdale A, Carson D, Hawkins R
Br J Cancer. 1992; 66(4):610-3.
PMID: 1419596
PMC: 1977416.
DOI: 10.1038/bjc.1992.324.
Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancer.
Gasparini G, Pozza F, Dittadi R, Meli S, Cazzavillan S, Bevilacqua P
J Cancer Res Clin Oncol. 1992; 118(7):557-63.
PMID: 1378057
DOI: 10.1007/BF01225273.